Anti−PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1

INTRODUCTION: Novel anticancer therapies include anti–programmed cell death protein-1 (PD-1) and anti–programmed death ligand-1 (PD-L1) drugs. These novel medications have side effects in different organs, including the kidney. The most common adverse effect in the kidney is acute interstitial nephr...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Kidney Int Rep
मुख्य लेखकों: Cassol, Clarissa, Satoskar, Anjali, Lozanski, Gerard, Rovin, Brad, Hebert, Lee, Nadasdy, Tibor, Brodsky, Sergey V.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2019
विषय:
Translational Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6698303/
https://ncbi.nlm.nih.gov/pubmed/31440705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.06.001
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन